U.S. Poultry Diagnostics Market
The United States is home to one of the largest poultry industries in the world, and safeguarding the health of this massive livestock population has become a growing priority for producers, veterinarians, and regulators alike. The U.S. Poultry Diagnostics Market has emerged as a critical segment within the broader animal health industry, encompassing instruments, consumables, kits, and testing technologies used to detect and monitor diseases in chickens, turkeys, and other domesticated birds. As poultry producers face mounting pressure to protect flock health, control zoonotic disease transmission, and maintain consistent supply chains for poultry-derived products, diagnostic solutions have become indispensable tools across veterinary hospitals, clinics, and diagnostic laboratories nationwide.
Market Size and Growth Outlook
The scale of this market underscores its importance to the U.S. agricultural economy. The U.S. poultry diagnostics market size was worth USD 445.4 million in 2023, according to Fortune Business Insight, and it is projected to grow at a compound annual growth rate (CAGR) of 11.3% during the forecast period extending through 2032. This steady growth trajectory reflects the increasing recognition among farmers, veterinarians, and government agencies of the need for timely and accurate disease detection to prevent widespread outbreaks that could devastate flocks and disrupt the nation's food supply.
The United States holds a unique position in the global poultry industry, being the world's largest poultry meat producer and the second-largest exporter of poultry meat, according to Fortune Business Insight. This dominant position brings with it a massive and growing bird population that requires vigilant health monitoring. The U.S. poultry sector includes more than 224 million turkeys and 518 million chickens, according to Fortune Business Insight, a population size that inherently increases susceptibility to disease outbreaks and reinforces the need for robust diagnostic infrastructure.
Key Market Drivers
Several factors are fueling demand for poultry diagnostics in the United States. Government-led educational initiatives are playing an increasingly important role, according to Fortune Business Insight, as authorities work to raise awareness among farmers about the importance of timely disease diagnosis in controlling zoonotic diseases and preserving flock health. These programs are helping bridge knowledge gaps that previously left many poultry operations vulnerable to undetected outbreaks.
The prevalence of poultry diseases themselves represents perhaps the most significant growth driver. The poultry population remains susceptible to a range of illnesses, including avian influenza, avian salmonellosis, Newcastle disease, mycoplasma, infectious bronchitis, and infectious bursal disease, according to Fortune Business Insight. The scale of these health threats is substantial: over 40,000 cases of poultry salmonellosis and 400 deaths due to acute salmonellosis are reported annually in the U.S., according to Fortune Business Insight. Avian influenza has proven especially disruptive, having infected more than 60 million chickens, turkeys, and other birds nationwide through October 2022, according to Fortune Business Insight. In a more localized snapshot, a poultry outbreak spanning 47 states affected more than 58 million commercial poultry and backyard flocks, according to Fortune Business Insight, while separate data indicated that 40.09 million birds across 36 states were infected with highly pathogenic avian influenza, with 382 flocks—186 commercial and 196 backyard—testing positive for the virus, according to Fortune Business Insight.
Emerging Trends
A notable shift is underway in how poultry diseases are diagnosed. The industry is transitioning from traditional laboratory-based testing toward point-of-care diagnostics, according to Fortune Business Insight, driven by the growing prevalence of infectious pathogens and the corresponding need for robust surveillance programs. Rapid diagnostic kits are gaining particular traction because they deliver quick results with minimal turnaround time, reducing both the economic burden on farmers and the need for veterinary visits. One standout example is a real-time PCR test that significantly reduced turnaround time for detecting Salmonella pathogens, demonstrating accuracy rates of 100.0%, 98.5%, and 98.9% across different disease diagnoses, according to Fortune Business Insight.
Market Segmentation
The market is segmented by product into instruments and consumables & kits, with the consumables & kits segment dominating market share in 2022, according to Fortune Business Insight, largely due to the high adoption of rapid diagnostic kits that reduce reliance on veterinary visits and prevent microbial transmission and culling.
By technology, the market spans enzyme-linked immunosorbent assay (ELISA), polymerase chain reaction (PCR), immunofluorescent assay, hemagglutination assay, and other methods. The ELISA segment held the largest market share in 2022, according to Fortune Business Insight, owing to its superior sensitivity and specificity in delivering accurate results.
By disease indication, the market is categorized into avian salmonellosis, avian influenza, Newcastle disease, mycoplasma, infectious bursal disease, and others, with avian influenza holding the dominant share in 2022, according to Fortune Business Insight, driven by the constant genetic mutation of the virus into increasingly contagious strains.
By end-user, the market includes veterinary hospitals & clinics, veterinary diagnostics laboratories, and others. Veterinary diagnostics laboratories led the market in 2022, according to Fortune Business Insight, reflecting the growing spread of poultry infections and regulatory efforts to monitor infected bird populations.
Restraining Factors
Despite strong growth prospects, the market faces certain headwinds. A persistent lack of guidance for poultry farmers regarding disease management practices continues to limit broader adoption of diagnostic products, according to Fortune Business Insight. This challenge was illustrated when a small flock of 50 birds in Vermont suffered mortality due to a highly pathogenic avian influenza outbreak, underscoring the ongoing need for greater public awareness and vigilance among poultry owners, farmers, and hunters.
Competitive Landscape
The competitive landscape features several established players. IDEXX Laboratories, Inc. dominated the U.S. market in 2022, according to Fortune Business Insight, supported by its extensive product portfolio and distribution network spanning more than 170 countries. Other notable companies include Zoetis Services LLC, whose FluDETECT and ProFLOK product lines diagnose diseases such as infectious bursal disease and avian influenza, and Thermo Fisher Scientific Inc., which has built a strong position through its laboratory diagnostics offerings. Additional key players include Biochek, BioNote, Vimian, GD, and Innovative Diagnostics, according to Fortune Business Insight.
Conclusion
The U.S. poultry diagnostics market stands at the intersection of public health, agricultural productivity, and technological innovation. With disease prevalence remaining a persistent challenge and diagnostic technologies continuing to evolve toward faster, more accessible point-of-care solutions, the market is well-positioned for sustained growth through 2032.
Source:https://www.fortunebusinessinsights.com/u-s-poultry-diagnostics-market-109157